Authorizes practitioners in institutional dispensers to dispense controlled substances as emergency treatment for use off the premises of the institutional dispenser; authorizes practitioners to dispense controlled substances for use in maintenance or detoxification treatment to an addict or habitual user.
This bill (A2311) prohibits local health offices from charging fees when issuing certificates for stillbirths or fetal deaths. It directly affects parents or families seeking official documentation for pregnancy losses. The law amends public health regulations to remove all fees for these specific certificates, replacing previous fee structures. The bill passed both legislative chambers in 2025 and was signed into law on November 21, 2025.
S 3294 updates New York's medical cannabis program by extending the validity of patient and caregiver registry cards from one to two years, streamlining certification processes for doctors, and clarifying possession limits. It requires practitioners to complete training before issuing certifications, allows special certifications for patients with progressive conditions, and permits patients to possess up to a 60-day supply of cannabis (aligning with existing penal law). The bill directly affects certified patients, designated caregivers, and healthcare providers by modernizing documentation, reducing administrative burdens, and updating expiration rules. It repeals the outdated Controlled Substances Therapeutic Research Act, consolidating the program under revised cannabis law provisions. This law took effect after being signed by the governor in November 2025.
This bill (S 3236) allows registered pharmacy technicians to work in any licensed pharmacy under the direct supervision of a licensed pharmacist. It permits technicians to assist with tasks like preparing, labeling, and dispensing prescriptions or medications - provided these tasks require no professional judgment (which remains the pharmacist's responsibility). The law requires pharmacists to be physically present during these tasks, authorize all work, and approve it before any medication is dispensed. The pharmacy must also ensure technicians receive proper training before they begin assisting. The bill is now law (signed November 21, 2025).
Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.
Requires hospitals to permit an interpreter to remain with a deaf, hard of hearing or nonverbal patient during admission to a hospital until appropriate hospital staff is assigned to interpret.
This bill adds a new option for New York residents to register for the Donate Life Registry (which facilitates organ, eye, and tissue donations) through mandatory electronic personal income tax filings. It requires the state to include a clear checkbox on tax forms asking, "Would you like to be added to the Donate Life Registry? Check box for 'yes' or 'skip this question'." This expands existing registration methods - which include driver's license applications, health insurance enrollment, and college financial aid forms - to include tax filings for those required to file electronically. The change applies to all taxpayers submitting income tax documents via electronic means, making organ donation registration more accessible during routine state interactions.
This bill (A 7321) would require New York health insurers to cover speech therapy for stuttering when recommended by a physician. It applies to all medical, major medical, and similar insurance plans, eliminating limits on the number of therapy sessions or visits. Coverage must be provided by licensed professionals and clarifies that school-based therapy (like IEPs) does not affect medical coverage for therapy outside educational settings. The bill was vetoed by the governor in October 2025 and did not become law.
Provides parity to durable medical equipment providers by requiring Medicaid managed care organizations to reimburse such providers at no less than one hundred percent of the medical assistance durable medical equipment and complex rehabilitation technology fee schedule for the same service or item.
Requires the department of health to establish a registry for the collection of information on the incidence and prevalence of amyotrophic lateral sclerosis (ALS) and motor neuron disease (MND) in the state; requires that every physician, nurse practitioner, physician assistant and general hospital that diagnoses or treats a patient diagnosed with ALS or MND give notice to the department of cases of ALS or MND coming under their care; requires that patients diagnosed with ALS or MND be provided with written and verbal notice regarding the collection of information and patient data on ALS and MND and provides a method for patients to opt out of the collection of data; provides for duties of the department and the commissioner of health in relation thereto.
